Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
Your ultimate guide to the 2024 North Carolina State Fair
Recommended
Find a flu shot
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Hims & Hers Health Inc
(NY:
HIMS
)
22.15
+0.59 (+2.74%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
6,348,404
Open
21.76
Bid (Size)
22.10 (1)
Ask (Size)
22.15 (10)
Prev. Close
21.56
Today's Range
21.10 - 22.16
52wk Range
5.650 - 25.74
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Hims & Hers' Incredible Growth Will Continue
October 18, 2024
GLP-1s get all the attention, but Hims & Hers' core business is where the rocket growth is.
Via
The Motley Fool
Hims & Hers Shares Have Rallied 22% This Week. Why That Move Is Now At Risk.
October 16, 2024
Hims & Hers has enjoyed a rally on an FDA decision regarding Eli Lilly's tirzepatide.
Via
Investor's Business Daily
Exposures
Product Safety
Performance
YTD
+129.77%
+129.77%
1 Month
+35.81%
+35.81%
3 Month
+14.06%
+14.06%
6 Month
+86.13%
+86.13%
1 Year
+266.12%
+266.12%
More News
Read More
Hims & Hers to Announce Third Quarter 2024 Financial Results on November 4, 2024
October 14, 2024
From
Hims & Hers
Via
Business Wire
Hims & Hers Health Stock Is Popping Monday: What's Behind The Move?
October 14, 2024
Via
Benzinga
Hims & Hers Health Pops After FDA Allows Compounded Copies Of Eli Lilly's Obesity Drug
October 14, 2024
Via
Investor's Business Daily
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
What Is Going On With Hims & Hers Stock?
October 11, 2024
Via
The Motley Fool
Where Does Hims & Hers Stock Go From Here?
October 12, 2024
Via
The Motley Fool
Exposures
Product Safety
2 Incredibly Cheap Growth Stocks to Buy Right Now
October 12, 2024
Via
The Motley Fool
2 No-Brainer Growth Stocks to Buy With $500 Right Now
October 12, 2024
Via
The Motley Fool
Top 3 Stocks with Explosive Call Option Activity: What to Watch
October 10, 2024
Via
MarketBeat
FDA Sparks Controversy With Sudden Removal Of Eli Lilly's Weight Loss Drug From Shortage List
October 08, 2024
Via
Benzinga
Exposures
Product Safety
Hims & Hers Stock Joins S&P 600: Is More Upside on the Horizon?
October 08, 2024
Via
MarketBeat
Topics
Stocks
Exposures
US Equities
With Its GLP-1 Drugs No Longer in a Shortage, Is Now the Time to Buy Eli Lilly Stock?
October 08, 2024
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
October 07, 2024
Via
Benzinga
Pfizer, Vista Outdoor, Duckhorn Portfolio And Other Big Stocks Moving Higher On Monday
October 07, 2024
Via
Benzinga
Hims & Hers Health Stock Is Rising Monday: What's Going On?
October 07, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Hims & Hers Health Asserts Demand For Its Compounded Weight Loss Offering To Continue Despite Resolved Supply Shortages
October 04, 2024
Via
Benzinga
Exposures
Product Safety
Massive News for Hims & Hers Stock: The Truth About Today's Move
October 04, 2024
Via
The Motley Fool
2 Winning Growth Stocks That Are Screaming Buys Right Now
October 04, 2024
Via
The Motley Fool
AngioDynamics, Ingevity, Levi Strauss And Other Big Stocks Moving Lower On Thursday
October 03, 2024
Via
Benzinga
Hims & Hers Health Stock Is Tumbling Thursday: Here's Why
October 03, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 03, 2024
Via
Benzinga
These 2 Healthcare Stocks With Big Catalysts on the Horizon Can Make You Richer
October 02, 2024
Via
The Motley Fool
Hims & Hers To Offer Access To Compounded Diabetes And Weight Loss Drugs For Just $99/Month To Certain Professional Personnel
September 19, 2024
Via
Benzinga
Hims & Hers to Offer Access to Compounded GLP-1 Injections for as Low as $99/Month to U.S. Military, Veterans, Teachers, Nurses and First Responders
September 18, 2024
From
Hims & Hers
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.